NEXULIS — Sovereign AI SOC Platform for Southeast Asia
Secure Intelligence. Delivered. Sovereign by default.
Your SOC is drowning. SQUDO investigates before your team looks.
SQUDO AI® automates 80% of Tier 1 triage and closes 94% of alerts without escalation, freeing your SOC to focus only on the threats that need a human, on sovereign infrastructure your regulator will accept on first review.
Who we serve: Healthcare Organizations (patient data, clinical continuity), Financial Institutions (regulated, audit-ready), Government Agencies (public sector, sovereign by mandate), Defence Agencies (classified, air-gapped capable), Educational Institutions (research, cultural heritage), Security MSSPs (managed SOC, multi-tenant).
What we build: four products, built for different jobs. SQUDO AI® (SOC platform) — the sovereign agentic AI SOC platform, every alert investigated to a verdict, with its reasoning shown, no black box. Image Classification System (agent). Sovereign GPT (enterprise AI). Customer Success Service (agent).
Why Nexulis: Sovereign by architecture, Swiss by engineering. Every product we ship is built on the same discipline: full data control, disciplined delivery and measurable outcomes.
01 Security by design — Protection and control are embedded at every layer, not added after deployment.
02 Built for critical environments — Engineered for stability, scalability and performance in high-risk, enterprise settings.
03 Execution without ambiguity — Clear scope, disciplined delivery and outcomes you can rely on.
04 Accountability at every layer — We take ownership from design to deployment, ensuring consistent results.
05 Outcome-driven by default — Every solution is built to deliver measurable impact, not experimentation.
06 Sovereign by architecture — Your data and systems remain fully controlled, compliant and protected.
Speak with NEXULIS. For enquiries about our solutions, products, partnerships or media, contact our team. We typically respond within one business day. Sales & demos, Partnerships, Media & press.
Visit NEXULIS